Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multi-organ involvement, characterized by periods of remission and flares. Severe disease manifestations and complications of immunosuppressive therapy are common reasons for emergency department visits. Nephrological, neurological, pulmonary, and hematological involvement may require urgent intervention. Lupus nephritis, thrombotic microangiopathy, and antiphospholipid syndrome can cause significant renal dysfunction. Neurological complications include stroke, seizures, neuropsychiatric lupus, and central nervous system vasculitis. Pulmonary emergencies such as acute lupus pneumonitis, diffuse alveolar hemorrhage, and pulmonary embolism are life-threatening, while cardiac involvement includes pericarditis, myocarditis, and accelerated atherosclerosis. Hematologic complications, including autoimmune hemolytic anemia, thrombocytopenia, and macrophage activation syndrome, are associated with high mortality. Infections are common in immunosuppressed patients and can mimic disease flares. During pregnancy, complications such as preeclampsia, Hemolysis, Elevated Liver enzymes, Low Platelets syndrome, neonatal lupus, and antiphospholipid syndrome-related thrombosis may arise. The management of SLE emergencies requires a multidisciplinary approach. Individualized treatment strategies following current guidelines and early intervention are crucial in reducing mortality.
Keywords: Systemic lupus erythematosus, emergency treatment, multiple organ failure
References
Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update on the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80:14-25.
Kaul A, Gordon C, Crow MK, Hughes GC, Kolfenbach JR, Costenbader KH. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.
Dörner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet. 2019;393:2344-58.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100:S1-276.
Nagai Y, Yokogawa N, Shimada K, Sugii S. Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus. Rheumatol Int. 2019;39:1567-73.
Dhital R, Pokharel A, Karageorgiou I, Poudel DR, Guma M, Kalunian K. Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS). Lupus. 2023;32:1646-55.
Panopalis P, Gillis JZ, Yazdany J, Schmajuk G, MacLean CH, Trupin L. Frequent use of the emergency department among persons with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62:401-8.
Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15-29.
Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110-21.
Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929-39.
Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521-30.
Navarra SV, Guzmán RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:721-31.
Mok CC. Biomarkers for lupus nephritis: a critical appraisal. J Biomed Biotechnol. 2010;2010:638413.
Gordon C, Amissah-Arthur MB, Gayed M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford). 2018;57:e1-e45.
Saxena A, Sorrento C, Izmirly P, et al. Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials. Lupus Sci Med. 2025;12:e001351.
Bandhan IH, Islam MN, Ahmad HI, Ahmedullah AK. Outcome of low-dose prednisolone use for the induction of remission in lupus nephritis patients. Int J Rheum Dis. 2022;25:121-30.
Zhou XJ, Chen M, Wang SX, Zhou FD, Zhao MH. A 3-year follow-up of a patient with acute renal failure caused by thrombotic microangiopathy related to antiphospholipid syndrome: case report. Lupus. 2017;26:777-82.
Kotzen ES, Roy S, Jain K. Antiphospholipid syndrome nephropathy and other thrombotic microangiopathies among patients with systemic lupus erythematosus. Adv Chronic Kidney Dis. 2019;26:376-86.
Bienaimé F, Legendre C, Terzi F, Canaud G. Antiphospholipid syndrome and kidney disease. Kidney Int. 2017;91:34-44.
Scheen M, Adedjouma A, Esteve E, et al. Kidney disease in antiphospholipid antibody syndrome: risk factors, pathophysiology and management. Autoimmun Rev. 2022;21:103072.
Lvovich S, Goldsmith DP. Neurological complications of rheumatic disease. Semin Pediatr Neurol. 2017;24:54-9.
Wang L, Chen H, Zhang Y, et al. Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in China. J Immunol Res. 2015;2015:540738.
Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE, Gonzalez-Lopez L, Gamez-Nava JI, Zavala-Cerna MG. Seizures in systemic lupus erythematosus: a scoping review. Seizure. 2021;86:161-7.
Rodrigues M, Galego O, Costa C, et al. Central nervous system vasculitis in systemic lupus erythematosus: a case series report in a tertiary referral centre. Lupus. 2017;26:1440-7.
Jain S, Khormi A, Sangle SR, D’Cruz DP. Transverse myelitis associated with systemic lupus erythematosus (SLE-TM): a review article. Lupus. 2023;32:1033-42.
Andreoli M, Hollenhorst CN, Malavia T, et al. A case report of systemic lupus erythematosus presenting as ısolated mononeuropathy multiplex. Neurohospitalist. Published online September 23, 2024.
Sayeed SKJB, Khan AH, Moniruzzaman M, Mahmud R, Rahman MM. Systemic lupus erythematosus with acute ischemic optic neuropathy complicated with neuromyelitis optica: a case report. J Med Case Rep. 2023;17:21.
Sarwar S, Mohamed AS, Rogers S, et al. Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus. 2021;13:e17969.
de Oliveira I, Sampaio Rocha-Filho PA. Headache and systemic lupus erythematosus: a narrative review. Headache. 2023;63:461-71.
Cantero C, Vongthilath R, Plojoux J. Acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus. BMJ Case Rep. 2020;13:e234638.
Jiménez-Zarazúa O, Vélez-Ramírez LN, Ramírez-Casillas CA, Mondragón JD. Pulmonary thromboembolism and alveolar hemorrhage as initial manifestations of systemic lupus erythematosus. Lupus. 2022;31:116-24.
Al-Adhoubi NK, Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus. 2020;29:355-63.
Andrade C, Mendonça T, Farinha F, et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus. 2016;25:75-80.
Dein E, Douglas H, Petri M, Law G, Timlin H. Pericarditis in lupus. Cureus. 2019;11:e4166.
du Toit R, Karamchand S, Doubell AF, Reuter H, Herbst PG. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice. Rheumatology (Oxford). 2023;62:523-34.
Melano-Carranza E, Zambrano-Zambrano A, Valle-Uitzil W, et al. Coronary artery disease in systemic lupus erythematosus: what do the facts say? Cureus. 2023;15:e33449.
Sanaka K, Mathew J, Hoque AR, Xu B. Outcomes and predictors of inpatient mortality for marantic endocarditis complicating systemic lupus erythematosus: contemporary nationwide study from the United States. Angiology. Published online September 26, 2024.
Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017;176:395-411.
Santacruz JC, Mantilla MJ, Rueda I, Pulido S, Rodriguez-Salas G, Londono J. A practical perspective of the hematologic manifestations of systemic lupus erythematosus. Cureus. 2022;14:e22938.
Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.
Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129:2829-35.
Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol. 2018;181:183-95.
Means RT Jr. Pure red cell aplasia. Blood. 2016;128:2504-9.
El-Husseini A, Hannan S, Awad A, Jennings S, Cornea V, Sawaya BP. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab. Am J Kidney Dis. 2015;65:127-30.
Poudel P, Swe T, Rayancha S. A rare case of macrophage activation syndrome presenting as the first manifestation of systemic lupus erythematosus. J Investig Med High Impact Case Rep. 2018;6:2324709618812196.
Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013;2013:605-11.
Gladman DD, Dhillon N, Su J, Urowitz MB. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus. 2018;27:76-81.
Shaharir SS, Chua SH, Mohd R, et al. Risk factors for symptomatic avascular necrosis (AVN) in a multi-ethnic systemic lupus erythematosus (SLE) cohort. PLoS One. 2021;16:e0248845.
Sodhi N, Acuna A, Etcheson J, et al. Management of osteonecrosis of the femoral head. Bone Joint J. 2020;102-B(7_Supple_B):122-8.
Zhao D, Zhang F, Wang B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J Orthop Translat. 2020;21:100-10.
Yin P, Li J, Wen Q, et al. Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients. Ren Fail. 2020;42:474-82.
Singh JA, Cleveland JD. Hospitalized infections in lupus: a nationwide study of types of infections, time trends, health care utilization, and in-hospital mortality. Arthritis Rheumatol. 2021;73:617-30.
García-Guevara G, Ríos-Corzo R, Díaz-Mora A, et al. Pneumonia in patients with systemic lupus erythematosus: epidemiology, microbiology and outcomes. Lupus. 2018;27:1953-9.
Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16:527-38.
Nguyen Y, Costedoat-Chalumeau N. Serious infections in patients with systemic lupus erythematosus: how can we prevent them? Lancet Rheumatol. 2023;5:e245-6.
Oud L, Garza J. The association of systemic lupus erythematosus with short-term mortality in sepsis: a population-level analysis. J Investig Med. 2023;71:419-28.
Suárez-Avellaneda A, Quintana JH, Aragón CC, et al. Systemic lupus erythematosus in the intensive care unit: a systematic review. Lupus. 2020;29:1364-76.
Andreoli L, Bertsias GK, Agmon-Levin N, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476-85.
Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060-8.
Gholizadeh Ghozloujeh Z, Singh T, Jhaveri KD, et al. Lupus nephritis: management challenges during pregnancy. Front Nephrol. 2024;4:1390783.
Muñoz CM, Goulden B, Ahmed K, Alijotas-Reig J, Giles I. Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review. Rheumatology (Oxford). 2023;62:497-511.
Tufano A, Coppola A, Maruotti GM, Martinelli P, Cerbone AM, Di Minno G. HELLP syndrome and its relation with the antiphospholipid syndrome. Blood Transfus. 2014;12:114-8.
Arachchillage DRJ, Laffan M. Pathogenesis and management of antiphospholipid syndrome. Br J Haematol. 2017;178:181-95.
de Ganzo Suárez T, de Paco Matallana C, Plasencia W. Spiral, uterine artery doppler and placental ultrasound in relation to preeclampsia. Best Pract Res Clin Obstet Gynaecol. 2024;92:102426.
Bankole A, Nwaonu J. A review of neonatal lupus syndrome. Sci Prog. 2024;107:368504241278476.
